Search
News
Important Only
RCI Hospitality Holdings Enters One-Year Employment Agreement With Interim CFO Albert Molina - SEC Filing
March 19 (Reuters) - SEC Filing:RCI HOSPITALITY HOLDINGS INC - ON MARCH 16, ENTERS ONE-YEAR EMPLOYMENT AGREEMENT WITH INTERIM CFO ALBERT MOLINA - SEC FILINGRCI HOSPITALITY HOLDINGS: Q4 REVENUE $70.9 MILLIONRCI HOSPITALITY HOLDINGS: Q4 ADJUSTED EPS $-0.12Source text: [ID:n0001628280-26-019809]Reuters
Thu, Mar 19
Firefly Aerospace Announces Fourth Quarter And Full Year 2025 Financial Results
March 19 (Reuters) - Firefly Aerospace Inc FLY.O:FIREFLY AEROSPACE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS WITH RECORD ANNUAL REVENUE UP 163% YEAR-OVER-YEARFIREFLY AEROSPACE INC - FIREFLY EXPECTS 2026 FULL-YEAR REVENUE TO BE BETWEEN $420 MILLION AND $450 MILLIONFIREFLY AEROSPAC...Reuters
Thu, Mar 19
Independent Bank Announces 8.5% Increase In Quarterly Dividend
March 19 (Reuters) - Independent Bank Corp (Massachusetts) INDB.O:INDEPENDENT BANK CORP. ANNOUNCES 8.5% INCREASE IN QUARTERLY DIVIDENDINDEPENDENT BANK CORP (MASSACHUSETTS) - DECLARES QTRLY CASH DIVIDEND OF $0.64 PER SHARE, UP $0.05 FROM PRIOR QUARTERReuters
Thu, Mar 19
Crane Harbor Acquisition Shareholders Approve Business Combination With Xanadu Quantum Technologies
March 19 (Reuters) - Crane Harbor Acquisition Corp CHAC.O:CRANE HARBOR ACQUISITION CORP. SHAREHOLDERS APPROVE BUSINESS COMBINATION WITH XANADU QUANTUM TECHNOLOGIES INC.CRANE HARBOR ACQUISITION CORP - COMBINED COMPANY TO BEGIN TRADING ON NASDAQ AND TSX UNDER TICKER XNDU ON MARCH 27, 2026Reuters
Thu, Mar 19
Electrocore Announces Full Year 2025 Financial Results And Organizational Changes
March 19 (Reuters) - electroCore, Inc. ECOR.O:ELECTROCORE ANNOUNCES FULL YEAR 2025 FINANCIAL RESULTS AND ORGANIZATIONAL CHANGESELECTROCORE: FOR FY 2026, CO PROVIDING REVENUE GUIDANCE OF ABOUT 30% ANNUAL REVENUE GROWTH OVER 2025ELECTROCORE, INC. - DAN GOLDBERGER TO RETIRE AS CEO EFFECTIVE APRIL 1, 20...Reuters
Thu, Mar 19
Scholastic Corporation Announces Intent To Repurchase Up To $200 Million Of Its Common Stock
March 19 (Reuters) - Scholastic Corp SCHL.O:SCHOLASTIC CORPORATION ANNOUNCES INTENT TO REPURCHASE UP TO $200 MILLION OF ITS COMMON STOCK THROUGH MODIFIED DUTCH AUCTION TENDER OFFERSCHOLASTIC CORP - TENDER OFFER PRICE RANGE SET AT $36.00-$40.00 PER SHAREReuters
Thu, Mar 19
Motor racing-Aston Martin say Newey stays principal amid media speculation
Aston Martin say Newey remains principalTeam struggling with power unit problemsAudi will not comment on Wheatley speculationBy Alan Baldwin LONDON, March 19 (Reuters) - Aston Martin said Adrian Newey remained principal of the struggling Formula One team as media speculation ramped up on Thursday...Reuters
Thu, Mar 19
Genie Energy Q4 prelim revenue rises
OverviewUS retail energy provider's preliminary Q4 revenue rose 18% yr/yrPreliminary Q4 income from operations fell sharply yr/yrCompany to restate 2023, 2024 annual results due to accounting errors in captive insurance subsidiaryOutlookGenie Energy projects 2026 consolidated Adjusted EBITDA of ...Reuters
Thu, Mar 19
US starts engaging drugmakers on putting Trump's MFN pricing into law
By Michael Erman and Mariam SunnyMarch 19 (Reuters) - The U.S. government has begun engaging pharmaceutical companies as it works to build consensus around legislation to write President Donald Trump's most-favored-nation drug pricing policy into law, HHS chief counsel Chris Klomp said on Thursd...Reuters
Thu, Mar 19
China makes arrests on fentanyl networks but US wants convictions
Fentanyl has led to tens of thousands of overdose deaths in United StatesUS official says Beijing should make 'seizures and convictions'US has linked the issue to tariffs on ChinaChina has defended its record on targeting criminalsBy Antoni Slodkowski and Michael Martina BEIJING/WASHINGTO...Reuters
Thu, Mar 19
Solid Biosciences Q4 net loss widens on higher R&D costs
OverviewUS genetic medicine developer's Q4 net loss widened yr/yr, driven by higher R&D expensesOutlookSolid anticipates cash runway to extend into H1 2028 after $240 mln private placementResult DriversSGT-003 COSTS - Higher R&D expenses were mainly due to increased manufacturing and cli...Reuters
Thu, Mar 19
Zura Bio's FY net loss widens on higher R&D costs
OverviewU.S. immunology drug developer's FY 2025 net loss widened due to higher R&D expensesCompany completed $144 mln public offering in Feb 2026 to bolster cash positionCash expected to fund planned operations through at least end of 2028OutlookTopline data from Phase 2 TibuSHIELD study in...Reuters
Thu, Mar 19
FiscalNote Q4 revenue falls, announces workforce reduction
OverviewUS policy intelligence provider's Q4 revenue fell 25% yr/yr, in line with company's guidanceAdjusted EBITDA for Q4 beat analyst expectations, despite a 25% yr/yr declineCompany to cut workforce by about 25% as part of AI-driven transformationOutlookFiscalNote sees 2026 revenue betwee...Reuters
Thu, Mar 19
Trump's envoy says 'great progress' in reconciling Belarus with Lithuania
By Andrius Sytas VILNIUS, March 19 (Reuters) - U.S. President Donald Trump's envoy John Coale said on Thursday he was "getting great progress" in reconciling Russian ally Belarus with its neighbour Lithuania, a NATO and European Union member.The two countries' relationship has bee...Reuters
Thu, Mar 19
THE DAY AHEAD-North America, March 20
To access a PDF version of this newsletter, please click hereYou can read The Day Ahead via TOPNEWS - U.S Companies or Canada page.If you would like to receive this newsletter through your email,please register at: https://solutions.lseg.com/TDA-subscription-pageFor Morning News Call U.S. -- a previ...Reuters
Thu, Mar 19
Eton Pharmaceuticals beats Q4 adjusted EPS estimates
OverviewU.S. rare disease drugmaker's Q4 product sales rose 83% yr/yr, driven by new launchesAdjusted EPS for Q4 beat analyst expectationsCompany launched DESMODA and acquired U.S. rights to HEMANGEOL, both expected to drive growthOutlookEton expects 2026 revenue to exceed $110 mlnCompany sees 2...Reuters
Thu, Mar 19
Tenon Medical Q4 revenue, gross profit surge
OverviewUS medical device maker's Q4 2025 revenue rose 92% yr/yr to $1.5 mlnGross profit for Q4 2025 increased 188% yr/yr, with gross margin rising to 69%OutlookCompany did not provide specific guidance for future quarters or the full year in press releaseResult DriversPROCEDURE GROWTH - Co said...Reuters
Thu, Mar 19
UK's NuCana Q4 net loss widens
OverviewUK biopharma firm's Q4 net loss widened yr/yrNuCana expects key clinical milestones for lead cancer drug NUC-7738 in 2026OutlookNuCana anticipates cash resources will fund operations into 2029Result DriversNON-CASH FINANCE EXPENSE - Co said net loss for the year included £12.6 mln non-ca...Reuters
Thu, Mar 19
